HEADER TRANSFERASE 01-DEC-18 6IBX
TITLE HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 5
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: PFK/FBPASE 3,6PF-2-K/FRU-2,6-P2ASE BRAIN/PLACENTA-TYPE
COMPND 5 ISOZYME,RENAL CARCINOMA ANTIGEN NY-REN-56,IPFK-2;
COMPND 6 EC: 2.7.1.105,3.1.3.46;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PFKFB3;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS CANCER, METABOLISM, KINASE, INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.BANASZAK,H.PAWLIK,A.BIALAS,C.H.FABRITIUS,M.NOWAK
REVDAT 4 24-JAN-24 6IBX 1 HETSYN
REVDAT 3 29-JUL-20 6IBX 1 COMPND REMARK HETNAM SITE
REVDAT 2 13-FEB-19 6IBX 1 JRNL
REVDAT 1 23-JAN-19 6IBX 0
JRNL AUTH N.BOUTARD,A.BIALAS,A.SABINIARZ,P.GUZIK,K.BANASZAK,A.BIELA,
JRNL AUTH 2 M.BIEN,A.BUDA,B.BUGAJ,E.CIELUCH,A.CIERPICH,L.DUDEK,
JRNL AUTH 3 H.M.EGGENWEILER,J.FOGT,M.GAIK,A.GONDELA,K.JAKUBIEC,M.JURZAK,
JRNL AUTH 4 A.KITLINSKA,P.KOWALCZYK,M.KUJAWA,K.KWIECINSKA,M.LES,
JRNL AUTH 5 R.LINDEMANN,M.MACIUSZEK,M.MIKULSKI,P.NIEDZIEJKO,A.OBARA,
JRNL AUTH 6 H.PAWLIK,T.RZYMSKI,M.SIEPRAWSKA-LUPA,M.SOWINSKA,
JRNL AUTH 7 J.SZEREMETA-SPISAK,A.STACHOWICZ,M.M.TOMCZYK,K.WIKLIK,
JRNL AUTH 8 L.WLOSZCZAK,S.ZIEMIANSKA,A.ZAREBSKI,K.BRZOZKA,M.NOWAK,
JRNL AUTH 9 C.H.FABRITIUS
JRNL TITL SYNTHESIS OF AMIDE AND SULFONAMIDE SUBSTITUTED N-ARYL
JRNL TITL 2 6-AMINOQUINOXALINES AS PFKFB3 INHIBITORS WITH IMPROVED
JRNL TITL 3 PHYSICOCHEMICAL PROPERTIES.
JRNL REF BIOORG. MED. CHEM. LETT. V. 29 646 2019
JRNL REFN ESSN 1464-3405
JRNL PMID 30626557
JRNL DOI 10.1016/J.BMCL.2018.12.034
REMARK 2
REMARK 2 RESOLUTION. 2.11 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.65
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 NUMBER OF REFLECTIONS : 44807
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.188
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.220
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1867
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3496
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 79
REMARK 3 SOLVENT ATOMS : 231
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 40.62
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.19
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.72000
REMARK 3 B22 (A**2) : -0.72000
REMARK 3 B33 (A**2) : 2.34000
REMARK 3 B12 (A**2) : -0.36000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.144
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.137
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.108
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.257
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6IBX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-DEC-18.
REMARK 100 THE DEPOSITION ID IS D_1200012968.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-AUG-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : BESSY
REMARK 200 BEAMLINE : 14.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46675
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.110
REMARK 200 RESOLUTION RANGE LOW (A) : 47.650
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 200 DATA REDUNDANCY : 10.44
REMARK 200 R MERGE (I) : 0.10100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.2600
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.11
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23
REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7
REMARK 200 DATA REDUNDANCY IN SHELL : 9.37
REMARK 200 R MERGE FOR SHELL (I) : 0.99200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.270
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 3QPU
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 68.37
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.89
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2% TACSIMATE, 10% PEG3350, 0.1M
REMARK 280 MES/IMIDAZOLE PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE
REMARK 280 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+1/6
REMARK 290 6555 X-Y,X,Z+5/6
REMARK 290 7555 Y,X,-Z+2/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+1/3
REMARK 290 10555 -Y,-X,-Z+1/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+5/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 169.62667
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.81333
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 127.22000
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.40667
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 212.03333
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 169.62667
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 84.81333
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 42.40667
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 127.22000
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 212.03333
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1550 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 19980 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 204 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 15 107.63 -49.27
REMARK 500 GLN A 80 136.06 -27.67
REMARK 500 LYS A 204 -88.46 -122.18
REMARK 500 GLU A 330 -8.76 78.34
REMARK 500 ASP A 350 74.61 -156.04
REMARK 500 GLU A 380 -110.68 -108.59
REMARK 500 CYS A 386 -138.17 -135.40
REMARK 500 ALA A 423 -124.26 55.90
REMARK 500
REMARK 500 REMARK: NULL
DBREF 6IBX A 3 446 UNP Q16875 F263_HUMAN 4 447
SEQADV 6IBX A UNP Q16875 ASP 18 DELETION
SEQADV 6IBX A UNP Q16875 HIS 19 DELETION
SEQADV 6IBX A UNP Q16875 ARG 20 DELETION
SEQADV 6IBX A UNP Q16875 PRO 21 DELETION
SEQADV 6IBX A UNP Q16875 SER 22 DELETION
SEQADV 6IBX A UNP Q16875 LEU 23 DELETION
SEQADV 6IBX A UNP Q16875 PRO 24 DELETION
SEQADV 6IBX A UNP Q16875 ARG 25 DELETION
SEQADV 6IBX A UNP Q16875 SER 26 DELETION
SEQADV 6IBX A UNP Q16875 CYS 27 DELETION
SEQADV 6IBX A UNP Q16875 GLY 28 DELETION
SEQADV 6IBX A UNP Q16875 PRO 29 DELETION
SEQADV 6IBX A UNP Q16875 LYS 30 DELETION
SEQADV 6IBX A UNP Q16875 LEU 31 DELETION
SEQADV 6IBX A UNP Q16875 THR 32 DELETION
SEQRES 1 A 429 GLU LEU THR GLN SER ARG VAL GLN LYS ILE TRP VAL PRO
SEQRES 2 A 429 VAL ASN SER PRO THR VAL ILE VAL MET VAL GLY LEU PRO
SEQRES 3 A 429 ALA ARG GLY LYS THR TYR ILE SER LYS LYS LEU THR ARG
SEQRES 4 A 429 TYR LEU ASN TRP ILE GLY VAL PRO THR LYS VAL PHE ASN
SEQRES 5 A 429 VAL GLY GLU TYR ARG ARG GLU ALA VAL LYS GLN TYR SER
SEQRES 6 A 429 SER TYR ASN PHE PHE ARG PRO ASP ASN GLU GLU ALA MET
SEQRES 7 A 429 LYS VAL ARG LYS GLN CYS ALA LEU ALA ALA LEU ARG ASP
SEQRES 8 A 429 VAL LYS SER TYR LEU ALA LYS GLU GLY GLY GLN ILE ALA
SEQRES 9 A 429 VAL PHE ASP ALA THR ASN THR THR ARG GLU ARG ARG HIS
SEQRES 10 A 429 MET ILE LEU HIS PHE ALA LYS GLU ASN ASP PHE LYS ALA
SEQRES 11 A 429 PHE PHE ILE GLU SER VAL CYS ASP ASP PRO THR VAL VAL
SEQRES 12 A 429 ALA SER ASN ILE MET GLU VAL LYS ILE SER SER PRO ASP
SEQRES 13 A 429 TYR LYS ASP CYS ASN SER ALA GLU ALA MET ASP ASP PHE
SEQRES 14 A 429 MET LYS ARG ILE SER CYS TYR GLU ALA SER TYR GLN PRO
SEQRES 15 A 429 LEU ASP PRO ASP LYS CYS ASP ARG ASP LEU SER LEU ILE
SEQRES 16 A 429 LYS VAL ILE ASP VAL GLY ARG ARG PHE LEU VAL ASN ARG
SEQRES 17 A 429 VAL GLN ASP HIS ILE GLN SER ARG ILE VAL TYR TYR LEU
SEQRES 18 A 429 MET ASN ILE HIS VAL GLN PRO ARG THR ILE TYR LEU CYS
SEQRES 19 A 429 ARG HIS GLY GLU ASN GLU HIS ASN LEU GLN GLY ARG ILE
SEQRES 20 A 429 GLY GLY ASP SER GLY LEU SER SER ARG GLY LYS LYS PHE
SEQRES 21 A 429 ALA SER ALA LEU SER LYS PHE VAL GLU GLU GLN ASN LEU
SEQRES 22 A 429 LYS ASP LEU ARG VAL TRP THR SER GLN LEU LYS SER THR
SEQRES 23 A 429 ILE GLN THR ALA GLU ALA LEU ARG LEU PRO TYR GLU GLN
SEQRES 24 A 429 TRP LYS ALA LEU ASN GLU ILE ASP ALA GLY VAL CYS GLU
SEQRES 25 A 429 GLU LEU THR TYR GLU GLU ILE ARG ASP THR TYR PRO GLU
SEQRES 26 A 429 GLU TYR ALA LEU ARG GLU GLN ASP LYS TYR TYR TYR ARG
SEQRES 27 A 429 TYR PRO THR GLY GLU SER TYR GLN ASP LEU VAL GLN ARG
SEQRES 28 A 429 LEU GLU PRO VAL ILE MET GLU LEU GLU ARG GLN GLU ASN
SEQRES 29 A 429 VAL LEU VAL ILE CYS HIS GLN ALA VAL LEU ARG CYS LEU
SEQRES 30 A 429 LEU ALA TYR PHE LEU ASP LYS SER ALA GLU GLU MET PRO
SEQRES 31 A 429 TYR LEU LYS CYS PRO LEU HIS THR VAL LEU LYS LEU THR
SEQRES 32 A 429 PRO VAL ALA TYR GLY CYS ARG VAL GLU SER ILE TYR LEU
SEQRES 33 A 429 ASN VAL GLU SER VAL CYS THR HIS ARG GLU ARG SER GLU
HET H9Z A 501 37
HET POP A 502 9
HET FLC A 503 13
HET F6P A 504 16
HET DMS A 505 4
HETNAM H9Z 3-[[8-(1-METHYLINDOL-6-YL)QUINOXALIN-6-YL]AMINO]-~{N}-
HETNAM 2 H9Z [(3~{S})-1-METHYLPIPERIDIN-3-YL]PYRIDINE-4-CARBOXAMIDE
HETNAM POP PYROPHOSPHATE 2-
HETNAM FLC CITRATE ANION
HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE
HETNAM DMS DIMETHYL SULFOXIDE
HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6-
HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE
FORMUL 2 H9Z C29 H29 N7 O
FORMUL 3 POP H2 O7 P2 2-
FORMUL 4 FLC C6 H5 O7 3-
FORMUL 5 F6P C6 H13 O9 P
FORMUL 6 DMS C2 H6 O S
FORMUL 7 HOH *231(H2 O)
HELIX 1 AA1 GLY A 46 ILE A 61 1 16
HELIX 2 AA2 VAL A 70 VAL A 78 1 9
HELIX 3 AA3 SER A 83 ARG A 88 5 6
HELIX 4 AA4 ASN A 91 GLU A 116 1 26
HELIX 5 AA5 THR A 129 ASN A 143 1 15
HELIX 6 AA6 ASP A 156 LYS A 168 1 13
HELIX 7 AA7 SER A 171 LYS A 175 5 5
HELIX 8 AA8 ASN A 178 ALA A 195 1 18
HELIX 9 AA9 ASP A 228 ILE A 241 1 14
HELIX 10 AB1 ASN A 256 GLN A 261 1 6
HELIX 11 AB2 SER A 271 ASN A 289 1 19
HELIX 12 AB3 LEU A 300 ALA A 309 1 10
HELIX 13 AB4 LYS A 318 ASN A 321 5 4
HELIX 14 AB5 ALA A 325 GLU A 329 5 5
HELIX 15 AB6 THR A 332 TYR A 340 1 9
HELIX 16 AB7 TYR A 340 ASP A 350 1 11
HELIX 17 AB8 SER A 361 GLN A 379 1 19
HELIX 18 AB9 HIS A 387 LEU A 399 1 13
HELIX 19 AC1 GLU A 405 LEU A 409 5 5
SHEET 1 AA1 2 LEU A 4 GLN A 6 0
SHEET 2 AA1 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5
SHEET 1 AA2 6 THR A 65 ASN A 69 0
SHEET 2 AA2 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68
SHEET 3 AA2 6 THR A 35 VAL A 40 1 N ILE A 37 O PHE A 123
SHEET 4 AA2 6 LYS A 146 VAL A 153 1 O LYS A 146 N VAL A 36
SHEET 5 AA2 6 LEU A 211 ILE A 215 1 O VAL A 214 N GLU A 151
SHEET 6 AA2 6 ARG A 220 ASN A 224 -1 O ARG A 220 N ILE A 215
SHEET 1 AA3 6 GLU A 315 GLN A 316 0
SHEET 2 AA3 6 ARG A 294 THR A 297 1 N VAL A 295 O GLU A 315
SHEET 3 AA3 6 VAL A 382 CYS A 386 1 O ILE A 385 N TRP A 296
SHEET 4 AA3 6 ILE A 248 ARG A 252 1 N TYR A 249 O VAL A 382
SHEET 5 AA3 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248
SHEET 6 AA3 6 GLY A 425 TYR A 432 -1 O ARG A 427 N THR A 420
CRYST1 102.782 102.782 254.440 90.00 90.00 120.00 P 65 2 2 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009729 0.005617 0.000000 0.00000
SCALE2 0.000000 0.011234 0.000000 0.00000
SCALE3 0.000000 0.000000 0.003930 0.00000